Evidence map›Paper›PMID 32933072›Full record

ArticleGenes2020

Enhanced Co-Expression Extrapolation (COXEN) Gene Selection Method for Building Anti-Cancer Drug Response Prediction Models.

Yitan Zhu, Thomas Brettin, Yvonne A Evrard, Fangfang Xia, Alexander Partin, Maulik Shukla, Hyunseung Yoo, James H Doroshow, Rick L Stevens

Abstract read
In one paragraph

Article in Genes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yitan ZhuComputing, Environment and Life Sciences, Argonne National Laboratory, Lemont, IL 60439, USA.
Thomas BrettinComputing, Environment and Life Sciences, Argonne National Laboratory, Lemont, IL 60439, USA.
Yvonne A EvrardLeidos Biomedical Research, National Laboratory for Cancer Research, Inc. Frederick, Frederick, MD 21702, USA.
Fangfang XiaComputing, Environment and Life Sciences, Argonne National Laboratory, Lemont, IL 60439, USA.
Alexander PartinComputing, Environment and Life Sciences, Argonne National Laboratory, Lemont, IL 60439, USA.ORCID 0000-0002-9279-9213
Maulik ShuklaComputing, Environment and Life Sciences, Argonne National Laboratory, Lemont, IL 60439, USA.
Hyunseung YooComputing, Environment and Life Sciences, Argonne National Laboratory, Lemont, IL 60439, USA.
James H DoroshowDevelopmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Rick L StevensComputing, Environment and Life Sciences, Argonne National Laboratory, Lemont, IL 60439, USA.

Funding

NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

The co-expression extrapolation (COXEN) method has been successfully used in multiple studies to select genes for predicting the response of tumor cells to a specific drug treatment. Here, we enhance the COXEN method to select genes that are predictive of the efficacies of multiple drugs for building general drug response prediction models that are not specific to a particular drug. The enhanced COXEN method first ranks the genes according to their prediction power for each individual drug and then takes a union of top predictive genes of all the drugs, among which the algorithm further selects genes whose co-expression patterns are well preserved between cancer cases for building prediction models. We apply the proposed method on benchmark in vitro drug screening datasets and compare the performance of prediction models built based on the genes selected by the enhanced COXEN method to that of models built on genes selected by the original COXEN method and randomly picked genes. Models built with the enhanced COXEN method always present a statistically significantly improved prediction performance (adjusted

Indexed as

Models, StatisticalAlgorithmsAntineoplastic AgentsBiomarkers, TumorDrug Screening Assays, AntitumorGene Expression ProfilingHumansNeoplasmsAntineoplastic AgentsBiomarkers, Tumorco-expression extrapolation (COXEN)general drug response prediction modelgene selectionprecision oncology

Identifiers

PMID32933072
PMCPMC7565427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.